Reported Oct 21, 2015 · Terminated

Bravelle 75 IU (urofollitropin for injection, purified) For Subcutaneous or Intramuscular Injection Only, 1 Carton…

Ferring Pharmaceuticals Inc.

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Ferring Pharmaceuticals Inc · 100 Interpace Pkwy · Parsippany, NJ · 07054-1149

Bravelle 75 IU (urofollitropin for injection, purified) For Subcutaneous or Intramuscular Injection Only, 1 Carton (contains 5 single dose vials of Bravelle, 5 single dose vials of 0.9% Sodium Chloride Inj., USP, 2 mL, and 5 Q-Cap Vial Adaptors) , Rx Only
Manufactured forFerring Pharmaceuticals, Inc. Parsippany, NJ 07054
ByFerring Gmbh, Kiel Germany, NDC 55566-8505-6

Lot codes and dates: Lot #'s: K11813A-1
K11813A-2
Exp 01/16
K11813B-1
K11813C-1
Exp 04/16
K13031A-1
K13031B-1
K13031B-2
Exp 05/16 additional lots added
H14942A-1
H14941A-2. H18815A-1
H15815B-1
H15815SMA-1
H16998A-1
H16998SMA-1
K10008A-1
K10008A-2
K11813A-2
K11813B-1
K11813C-1
K13031A-1
K13031B-1
K13031B-2
K13503SMA-1
K13503A-1
K13503B-1
K13512A-1
K13512A-2
K1392A-1
K13921A-2
K13921B-1
K14616A-1
K14616A-2
K15917A-1
K15917SMA-1
K15917SMA-2
K17006AA
K18201AA
K18202AA
L10403AA
L10403AB
L10840AA
L10992AA
Amount recalled: 32,341 vials

Subpotent Drug

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.

8 in total.